Self-reported antibiotic allergy incidence and prevalence: age and sex effects.

BACKGROUND Data on the prevalence and incidence of adverse reactions to antibiotics in outpatient populations are rare. These events are commonly called "allergy" when noted in the medical record. OBJECTIVES Determine the prevalence and incidence of allergy, as recorded in the medical record, to the most commonly used antibiotic classes in a large outpatient population using health care in the United States during 2007. METHODS Data for drug allergy and antibiotic use were extracted from the electronic health records of 411,543 patients cared for by Kaiser Permanente in San Diego County who had at least one outpatient visit during 2007. Outpatient antibiotic utilization data was obtained for each year between 1995 and 2007. Penicillins, sulfas, cephalosporins, tetracyclines, macrolides, and quinolones were the classes of antibiotics evaluated. RESULTS Antibiotics account for a majority of drug allergy entries. Antibiotic classes with higher historical use have higher allergy prevalence. Female patients use more antibiotics than males, and have higher allergy prevalence rates for all classes of antibiotics. There is a steady increase in antibiotic allergy prevalence with aging for both sexes. Females have higher allergy incidence rates for all classes of antibiotics. Antibiotic allergy incidence in female patients is highest for sulfas, 3.4%, compared with 1%-1.5% for all other classes of antibiotics. Antibiotic allergy incidence in males also is highest for sulfas, 2.2%, compared with 1.1% for penicillins and 0.5%-0.6% for all other classes of antibiotics. CONCLUSIONS Female sex, use, and increasing age are the primary factors that account for higher antibiotic allergy prevalence. Antibiotic allergy incidence is highest with sulfa class antibiotics.

[1]  E. Rietschel,et al.  Questionnaire‐based survey of lifetime‐prevalence and character of allergic drug reactions in German children , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[2]  A. Arroliga,et al.  A Prospective Observational Study of the Effect of Penicillin Skin Testing on Antibiotic Use in the Intensive Care Unit , 2003, Infection Control & Hospital Epidemiology.

[3]  James T.C. Li,et al.  Female sex as a risk factor for penicillin allergy. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  B. Martin,et al.  Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis. , 2002, Clinical therapeutics.

[5]  Arjun Srinivasan,et al.  Emergency department visits for antibiotic-associated adverse events. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  David W. Bates,et al.  Research Paper: Using Computerized Data to Identify Adverse Drug Events in Outpatients , 2001, J. Am. Medical Informatics Assoc..

[7]  D. Pollock,et al.  Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) , 2007, Medical care.

[8]  P. Demoly,et al.  Epidemiology of hypersensitivity drug reactions , 2005 .

[9]  M. Bigby.  Rates of cutaneous reactions to drugs. , 2001, Archives of dermatology.

[10]  C. Naranjo,et al.  Sex-related variations in the frequency and characteristics of adverse drug reactions. , 1980, International journal of clinical pharmacology, therapy, and toxicology.

[11]  D. Withington.  Allergy, anaphylaxis and anaesthesia , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[12]  John D Seeger,et al.  Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation , 2007, Drug safety.

[13]  Sean Hennessy,et al.  Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. , 2003, The New England journal of medicine.

[14]  T. Casale,et al.  Manual of Allergy and Immunology , 1998 .

[15]  M. Rieder,et al.  Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. , 2007, The Cochrane database of systematic reviews.

[16]  M. Blaiss,et al.  Drug allergy. , 1988, Pediatric clinics of North America.

[17]  O. Hung,et al.  Drug allergies in the surgical population , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[18]  M. Schatz,et al.  The falling rate of positive penicillin skin tests from 1995 to 2007. , 2009, The Permanente journal.

[19]  L. Mandell,et al.  Adverse Cutaneous Reactions and Drugs: A Focus on Antimicrobials , 2006, Journal of chemotherapy.

[20]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Margolis,et al.  Represcription of penicillin after allergic-like events. , 2004, The Journal of allergy and clinical immunology.

[22]  D. Bruynzeel,et al.  [Cutaneous reactions to drugs]. , 2004, Nederlands tijdschrift voor geneeskunde.

[23]  P. Demoly,et al.  Self‐reported drug allergy in a general adult Portuguese population , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  M. Schatz,et al.  Routine Penicillin Skin Testing in Hospitalized Patients with a History of Penicillin Allergy. , 2004, The Permanente journal.

[25]  P. Demoly,et al.  Drug hypersensitivity: epidemiology and risk factors. , 2006, Current pharmaceutical design.

[26]  L. Naldi,et al.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. , 1999, British journal of clinical pharmacology.

[27]  K. Arndt,et al.  Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. , 1986, JAMA.